Product details

Share this page:
Published by:
IMD (2005)
Version:
24.10.2016
Revision date:
05-Jan-2017
Length:
17 pages
Data source:
Field research

Abstract

This is the second of a three-case series (IMD-1-0240 to IMD-1-0242). Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyse and structure the next financing round. Venture Valuation has to, given a very tight deadline, customise the evaluation process to using quantitative and qualitative data to best meet its customers needs. The case outlines the task ahead of Venture Valuation and requires students to make assessments and calculations and finally come up with a valuation for the start-up, Genedata. A supplement (IMD-1-0241-H) is available to accompany this case.

Topics

Venture capital; Entrepreneurship; Valuation; Pharmaceutical; Start-up; Company; Finance
Location:
Size:
Small, start-up
Other setting(s):
July 1999

Access this item

casecent.re/p/69325
View our pricing guide
or to see prices.

Reviews & usage